Cargando…
Cyto-genotoxicity Assessment of Potential Anti-tubercular Drug Candidate Molecule-trans-cyclohexane-1, 4-diamine Derivative-9u in Human Lung Epithelial Cells A549
Increasing incidences of multiple drug-resistance (MDR) in Mycobacterium tuberculosis are emerging as one among the serious public health threats and socio-economic burden to the third world countries including India. Last couples of decades are witnesses of the dedicated and sustained efforts made...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3989918/ https://www.ncbi.nlm.nih.gov/pubmed/24748738 http://dx.doi.org/10.4103/0971-6580.128800 |
_version_ | 1782312204847022080 |
---|---|
author | Kapoor, Ekta Tripathi, Vinay Kumar, Vivek Juyal, Vijay Bhagat, Sunita Ram, Veerma |
author_facet | Kapoor, Ekta Tripathi, Vinay Kumar, Vivek Juyal, Vijay Bhagat, Sunita Ram, Veerma |
author_sort | Kapoor, Ekta |
collection | PubMed |
description | Increasing incidences of multiple drug-resistance (MDR) in Mycobacterium tuberculosis are emerging as one among the serious public health threats and socio-economic burden to the third world countries including India. Last couples of decades are witnesses of the dedicated and sustained efforts made toward the development of target specific and cost-effective antimicrobial agents against MDR-M. tuberculosis. However, the drugs in use are still incapable of controlling the upsurge of MDR. Thus, in order to address the issue, we synthesized a library of symmetrical trans-cyclohexane-1, 4-diamine derivatives and evaluated their anti-mycobacterium activity in H(37)RV strain of M. tuberculosis. A range of efficacy has been recorded in different derivatives of synthesized compounds and compound “9u” having i-propyl group substitution at p-position, was found to have more significant detrimental effects against the tested strain of M. tuberculosis. The present investigations were aimed to study whether the effective anti-mycobacterium concentrations of “9u” are biologically safe to human cells or not? The human lung epithelial cell line-A549 were exposed to a range of concentrations, i.e., at and above the anti-mycobacterium effective dose of “9u” for a period of 0-96 h. The standard endpoints of cytotoxicity viz., tetrazolium bromide salt (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide), neutral red uptake, lactate dehydrogenase release, trypan blue dye exclusion assays; and genotoxicity viz., micronucleus and chromosomal aberrations assays were used to evaluate the bio-safety of test compound. The compound “9u” shows no significant cytotoxicity and genotoxicity in A549 cells exposed to 10(-5) M for 72 h, a concentration substantially higher than the concentration kill the H(37)Rv strain of M. tuberculosis. The compound 9u was found to be safe up to 10(-4) M if given for 24 h. The data reveal the therapeutic potential of compound 9u against M. tuberculosis without any having any cytotoxicity and genotoxicity responses. |
format | Online Article Text |
id | pubmed-3989918 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-39899182014-04-18 Cyto-genotoxicity Assessment of Potential Anti-tubercular Drug Candidate Molecule-trans-cyclohexane-1, 4-diamine Derivative-9u in Human Lung Epithelial Cells A549 Kapoor, Ekta Tripathi, Vinay Kumar, Vivek Juyal, Vijay Bhagat, Sunita Ram, Veerma Toxicol Int Original Article Increasing incidences of multiple drug-resistance (MDR) in Mycobacterium tuberculosis are emerging as one among the serious public health threats and socio-economic burden to the third world countries including India. Last couples of decades are witnesses of the dedicated and sustained efforts made toward the development of target specific and cost-effective antimicrobial agents against MDR-M. tuberculosis. However, the drugs in use are still incapable of controlling the upsurge of MDR. Thus, in order to address the issue, we synthesized a library of symmetrical trans-cyclohexane-1, 4-diamine derivatives and evaluated their anti-mycobacterium activity in H(37)RV strain of M. tuberculosis. A range of efficacy has been recorded in different derivatives of synthesized compounds and compound “9u” having i-propyl group substitution at p-position, was found to have more significant detrimental effects against the tested strain of M. tuberculosis. The present investigations were aimed to study whether the effective anti-mycobacterium concentrations of “9u” are biologically safe to human cells or not? The human lung epithelial cell line-A549 were exposed to a range of concentrations, i.e., at and above the anti-mycobacterium effective dose of “9u” for a period of 0-96 h. The standard endpoints of cytotoxicity viz., tetrazolium bromide salt (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide), neutral red uptake, lactate dehydrogenase release, trypan blue dye exclusion assays; and genotoxicity viz., micronucleus and chromosomal aberrations assays were used to evaluate the bio-safety of test compound. The compound “9u” shows no significant cytotoxicity and genotoxicity in A549 cells exposed to 10(-5) M for 72 h, a concentration substantially higher than the concentration kill the H(37)Rv strain of M. tuberculosis. The compound 9u was found to be safe up to 10(-4) M if given for 24 h. The data reveal the therapeutic potential of compound 9u against M. tuberculosis without any having any cytotoxicity and genotoxicity responses. Medknow Publications & Media Pvt Ltd 2014 /pmc/articles/PMC3989918/ /pubmed/24748738 http://dx.doi.org/10.4103/0971-6580.128800 Text en Copyright: © Toxicology International http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Kapoor, Ekta Tripathi, Vinay Kumar, Vivek Juyal, Vijay Bhagat, Sunita Ram, Veerma Cyto-genotoxicity Assessment of Potential Anti-tubercular Drug Candidate Molecule-trans-cyclohexane-1, 4-diamine Derivative-9u in Human Lung Epithelial Cells A549 |
title | Cyto-genotoxicity Assessment of Potential Anti-tubercular Drug Candidate Molecule-trans-cyclohexane-1, 4-diamine Derivative-9u in Human Lung Epithelial Cells A549 |
title_full | Cyto-genotoxicity Assessment of Potential Anti-tubercular Drug Candidate Molecule-trans-cyclohexane-1, 4-diamine Derivative-9u in Human Lung Epithelial Cells A549 |
title_fullStr | Cyto-genotoxicity Assessment of Potential Anti-tubercular Drug Candidate Molecule-trans-cyclohexane-1, 4-diamine Derivative-9u in Human Lung Epithelial Cells A549 |
title_full_unstemmed | Cyto-genotoxicity Assessment of Potential Anti-tubercular Drug Candidate Molecule-trans-cyclohexane-1, 4-diamine Derivative-9u in Human Lung Epithelial Cells A549 |
title_short | Cyto-genotoxicity Assessment of Potential Anti-tubercular Drug Candidate Molecule-trans-cyclohexane-1, 4-diamine Derivative-9u in Human Lung Epithelial Cells A549 |
title_sort | cyto-genotoxicity assessment of potential anti-tubercular drug candidate molecule-trans-cyclohexane-1, 4-diamine derivative-9u in human lung epithelial cells a549 |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3989918/ https://www.ncbi.nlm.nih.gov/pubmed/24748738 http://dx.doi.org/10.4103/0971-6580.128800 |
work_keys_str_mv | AT kapoorekta cytogenotoxicityassessmentofpotentialantituberculardrugcandidatemoleculetranscyclohexane14diaminederivative9uinhumanlungepithelialcellsa549 AT tripathivinay cytogenotoxicityassessmentofpotentialantituberculardrugcandidatemoleculetranscyclohexane14diaminederivative9uinhumanlungepithelialcellsa549 AT kumarvivek cytogenotoxicityassessmentofpotentialantituberculardrugcandidatemoleculetranscyclohexane14diaminederivative9uinhumanlungepithelialcellsa549 AT juyalvijay cytogenotoxicityassessmentofpotentialantituberculardrugcandidatemoleculetranscyclohexane14diaminederivative9uinhumanlungepithelialcellsa549 AT bhagatsunita cytogenotoxicityassessmentofpotentialantituberculardrugcandidatemoleculetranscyclohexane14diaminederivative9uinhumanlungepithelialcellsa549 AT ramveerma cytogenotoxicityassessmentofpotentialantituberculardrugcandidatemoleculetranscyclohexane14diaminederivative9uinhumanlungepithelialcellsa549 |